AfA celebrates 25 years of HIV Management Excellence
As part of the greater Afrocentric Group of Companies, Aid for Aids (“AfA”) designs, develops and delivers unique and encompassing programmes that help businesses and medical schemes care for individuals living with HIV/AIDS. Find out more about this highly successful part of our business.
AfA started in 1998 when it was the tragic norm for Human Immunodeficiency Virus (HIV) infection to progress to Acquired Immune Deficiency Syndrome (AIDS), and for individuals to battle many opportunistic infections and be hospitalised as a result. The establishment of the AfA programme managed to change that inevitability for its members and gave them a real chance of improving their health.
Many clients have stuck with us since 1998 — a testament to the value we bring and the quality of the relationships we take great care to develop.
Our model facilitates the integration of all services, from prevention (HIV awareness education) to treatment and optimising the clinical wellbeing of beneficiaries registered on the programme. As the preferred partner in HIV disease management, AfA serves as care coordinator between the funder, doctors, pathology laboratories, pharmacists, and patients.
The drive toward Undetectable Equals HIV Untransmittable (U=U)
UNAIDS (United Nations Programme on HIV and AIDS) laboratories updated their 2025 AIDS targets. The revised 95-95-95 target proposes that 95% of people with HIV know their HIV status, and of those that know their status, 95% initiate antiretroviral therapy (ART), and of those on treatment, 95% are virally suppressed.
AfA’s role in achieving U=U
The AfA HIV managed population has grown to almost 400 000 in recent years and in 2023, AfA managed to get 99.3% of its patients on ART. Of these patients, 93.6% are virally suppressed. We therefore have a good understanding of the burden of HIV and are uniquely positioned to deliver an HIV management programme that achieves the desired outcomes.
Quick facts
- First place PMR Africa Diamond Award for HIV Disease Management (2019 to 2023 consecutively).
- A successful HIV Management Programme is evidenced by clinical outcomes. 93.6% of our patients are virally suppressed.
- Dedicated team of experienced and internationally acknowledged HIV specialists and pharmacists ensuring expert reviews of clinical protocols and guidelines.
- Bespoke Disease Management System to manage HIV beneficiaries that integrates nationally with pathology laboratories.
- Clinical policy-making and support for complex cases through our dedicated independent Clinical Advisory Committee, comprising many of South Africa‘s leading HIV clinicians.
- Ongoing counselling and coaching for patients; adherence monitoring, management and risk stratification to trigger appropriate intervention.
